- Renowned Australian cancer specialist Richard Scolyer has died at 59 after battling an aggressive glioblastoma; he publicly documented his treatment and wrote a moving final letter.
- He underwent a risky world‑first pre‑surgery combination immunotherapy plus a personalized vaccine — an experimental approach that showed promising results and has prompted an early-stage US clinical trial.
- Alongside colleague Georgina Long, Scolyer helped revolutionize melanoma treatment with immunotherapy (lifting long‑term survival dramatically), was named 2024 Australian of the Year, and urged continued scientific bravery and funding.
The news, distilled into what matters.
Get the full experience in the app — topics, comments, and audio summaries.